Cover Image

Triple Analysis: Lymphoma, Pancreatic Cancer and Cancer Vaccines

Abstract

DESCRIPTION

This triple analysis focuses on cancer drug development strategies in both Lymphoma and Pancreatic Cancer and by the mechanism/target/effect of Cancer Vaccines. Each of these three individual parts is evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different areas.

Table of Contents

KEY TOPICS COVERED:

Part I: Lymphoma

  • 5.1. The Scope of this Report
  • 6. Consider the Therapeutic Target Among Lymphoma Drugs for the Highest Therapeutic Outcome and Return on Investment (181 Drug Targets)
  • 7. Emerging New Products to Established Ones: Drug Target Strategies of Lymphoma Drugs by their Highest Stage of Development (173 Drug Target Strategies and 282 Lymphoma Drugs)
  • 8. Compound Strategies at Work: Competitive Benchmarking of Lymphoma Drugs by Compound Strategy (8 Compound Strategies)
  • 9. Selecting Subindication for Lymphoma Drugs (Five Subindications of Lymphoma)
  • 10. Pipeline and Portfolio Planning: Competitive Benchmarking of the Lymphoma Drug Pipeline by Investigator (152 Companies)
  • 11. Disclaimer
  • 12. Drug Index
  • 13. Company Index
  • Figures: Includes 6 Figures
  • Tables: Includes 222 Tables
  • Total Number of Pages: 954

Part II: Pancreatic Cancer

  • 5.1. The Scope of this Report
  • 6. Consider the Therapeutic Target for the Highest Therapeutic Outcome and Return on Investment (171 Drug Targets)
  • 7. The Rise of New Products: How Mature, Unique and Clinically Validated are the Drug Target Strategies Identified in the Pancreatic Cancer Therapeutic Pipeline? (142 Drug Target Strategies and 213 Drugs)
  • 8. Compound Strategies at Work: Competitive Benchmarking of Pancreatic Cancer Drugs by Compound Strategy (8 Different Compound Strategies)
  • 9. Pipeline and Portfolio Planning: Competitive Benchmarking of Pancreatic Cancer Therapeutic Pipeline by Investigator (137 Investigators)
  • 11. Drug Index
  • 12. Company Index
  • Figures: Includes 5 Figures
  • Tables: Includes 193 Tables
  • Total Number of Pages: 610

Part III: Cancer Vaccines

  • 5.1. The Scope of this Report
  • 6. Consider the Therapeutic Target Among Cancer Vaccine Drugs for the Highest Therapeutic Outcome and Return on Investment (94 Drug Targets)
  • 7. Emerging New Products to Established Ones: Drug Target Strategies of Cancer Vaccine Drugs by their Highest Stage of Development (91 Drug Target Strategies and 155 Cancer Vaccine Drugs)
  • 8. Compound Strategies at Work: Competitive Benchmarking of Cancer Vaccine Drugs by Compound Strategy (7 Compound Strategies)
  • 9. Selecting Cancer Indications for Cancer Vaccine Drugs (42 Cancer Indications)
  • 10. Pipeline and Portfolio Planning: Competitive Benchmarking of the Cancer Vaccine Drug Pipeline by Investigator (99 Investigators)
  • 11. Disclaimer
  • 12. Drug Index
  • 13. Company Index
  • Figures: Includes 6 Figures
  • Tables: Includes 205 Tables
  • Total Number of Pages: 659

FEATURED COMPANIES:

This Report Includes the Following Companies:

  • 4SC
  • Abbott
  • Abiogen
  • Abraxis BioScience
  • AC Immune
  • Active Biotech
  • Adaptimmune
  • Adherex
  • Aduro BioTech
  • Advantagene
  • Advaxis
  • AEgera
  • AEterna Zentaris
  • Affimed Therapeutics
  • Agenus
  • Aida Pharmaceuticals
  • Akela Pharma
  • Alfa Wassermann
  • Alfacell
  • Allos Therapeutics
  • AlphaVax
  • Ambit Biosciences
  • Amgen
  • Antisense Pharma
  • Apotex
  • Apricus Biosciences
  • Apthera
  • Archer Biosciences
  • Ariad
  • Arno Therapeutics
  • ArQule
  • Array BioPharma
  • Ascenta Therapeutics
  • Astellas
  • Astex Therapeutics
  • AstraZeneca
  • Attenuon
  • AVEO
  • AVI BioPharma
  • Bavarian Nordic
  • Bayer
  • Bellicum Pharmaceuticals
  • Benitec
  • Biocon
  • BioCryst Pharmaceuticals
  • Biogen Idec
  • Biolex
  • Bionovo
  • BioNumerik
  • Biostar
  • BioVex
  • Boehringer Ingelheim
  • Borean Pharma
  • Bristol-Myers Squibb
  • BTG
  • Cadila
  • Cancer Research Technology
  • Celera
  • Celgene
  • Cell Genesys
  • Cell Therapeutics
  • Celldex Therapeutics
  • Celltrion
  • Celsion
  • Celtic Pharma
  • Center of Molecular Immunology
  • Cephalon
  • CG Therapeutics
  • CompleGen
  • Cornerstone Pharmaceuticals
  • Cosmo Pharmaceuticals
  • CSL
  • CureTech
  • Curis
  • Cyclacel
  • Cylene Pharmaceuticals
  • Cynvec
  • CytImmune Sciences
  • Cytokinetics
  • Daiichi Sankyo
  • Dainippon Sumitomo Pharma
  • Dara Biosciences
  • Dendreon
  • DeveloGen
  • Dr Reddy' s
  • Dynavax Technologies
  • EGEN Inc
  • Eisai
  • Elan
  • Eleos
  • Eli Lilly
  • Emergent BioSolutions
  • EntreMed
  • Enzon
  • Epeius Biotechnologies
  • EpiCept
  • Epizyme
  • Exelixis
  • Facet Biotech
  • Favrille
  • Forma Therapeutics
  • Gemin X Biotechnologies
  • Genencor
  • Genentech
  • Generex
  • Genmab
  • GenOdyssee Pharmaceuticals
  • GenPat77
  • Genta
  • GENTICEL
  • GenVec
  • Genzyme
  • Geron
  • Gilead Sciences
  • GlaxoSmithKline
  • Gliknik
  • GlobeImmune
  • Gloucester Pharmaceuticals
  • GlycoGenesys
  • Gradalis
  • Hana Biosciences
  • Hayashibara
  • Heber Biotec
  • HemaQuest
  • Hoffmann-La Roche
  • Human Genome Sciences
  • Hy BioPharma
  • Ichor Medical Systems
  • Idera Pharmaceuticals
  • IGF Oncology
  • ImmunoCellular Therapeutics
  • ImmunoFrontier
  • ImmunoGen
  • Immunomedics
  • Immunotope
  • Immutep
  • Inex
  • Innate Pharma
  • InNexus Biotechnology
  • Innovive
  • Inovio
  • Intas Biopharmaceuticals
  • Intracel
  • Introgen Therapeutics
  • Ipsen
  • ISA Pharmaceuticals
  • Italfarmaco
  • Johnson & Johnson
  • Kinex
  • Kissei
  • Kyowa Hakko Kirin
  • Leo
  • LG Life Sciences
  • Ligand
  • Lorus Therapeutics
  • MacroGenics
  • Meda
  • Medical Marketing International
  • MediGene
  • MedImmune
  • Medisyn Technologies
  • Menarini
  • Merck & Co
  • Merck KGaA
  • MethylGene
  • Micromet
  • MolMed
  • Mologen
  • Nektar Therapeutics
  • Nemod Biotherapeutics
  • NeoPharm
  • Neovacs
  • Nereus Pharmaceuticals
  • Nerviano Medical Sciences
  • NIH
  • Nippon Kayaku
  • Nippon Shinyaku
  • Northwest Biotherapeutics
  • Novartis
  • NovaRx
  • Novogen
  • Noxxon
  • Nycomed Pharma
  • OncoMune
  • Onconova
  • OncoTherapy Science
  • Oncothyreon
  • Oncovir
  • Onyvax
  • OSI Pharmaceuticals
  • Otsuka
  • Oxford BioMedica
  • OXiGENE
  • Paladin Labs
  • PanaGin
  • Pepscan Systems
  • Pepscan Therapeutics
  • Pfizer
  • Pharmacyclics
  • PharmaEngine
  • PharmaMar
  • Pharmexa
  • Philogen
  • Pierre Fabre
  • Piramal
  • Plexxikon
  • Portola Pharmaceuticals
  • Prima Biomed
  • Pro-Pharmaceuticals
  • Progenics Pharmaceuticals
  • ProNAi Therapeutics
  • Protherics
  • Radient Pharmaceuticals
  • Reata Pharmaceuticals
  • Receptor BioLogix
  • Regeneron
  • Regulon
  • Reliance Life Sciences
  • responsif
  • RESprotect
  • Rexahn
  • Rigel
  • Samyang
  • Sanofi-Aventis
  • Santaris Pharma
  • SBIO
  • Scancell
  • SciClone Pharmaceuticals
  • Seattle Genetics
  • Selvita
  • Semafore Pharmaceuticals
  • Shire
  • SuperGen
  • SuppreMol
  • Synageva BioPharma
  • Taiho
  • Takeda
  • Tapestry Pharmaceuticals
  • TapImmune
  • Tau Therapeutics
  • Tekmira Pharmaceuticals
  • Telik
  • TetraLogic Pharmaceuticals
  • Teva
  • Thallion Pharmaceuticals
  • Therion Biologics
  • Titan Pharmaceuticals
  • TopoTarget
  • Tragara Pharmaceuticals
  • Transgene
  • Trion Pharma
  • United Biomedical
  • Vaccinex
  • Vaxil BioTherapeutics
  • Vaxon Biotech
  • VaxOnco
  • Vectura
  • VentiRx Pharmaceuticals
  • Vertex Pharmaceuticals
  • Vical
  • Wilex
  • Vion Pharmaceuticals
  • VioQuest
  • Viragen
  • Virionics
  • ViroMed
  • XBiotech
  • Xencor
  • Xerion
  • Yakult Honsha
  • YM BioSciences
  • Zenotech
  • Zensun
  • Zenyaku Kogyo
  • Zhejiang Beta Pharma
  • A Shortlist of Drugs Included are:
  • 131I-tositumomab
  • ADXS11-001
  • AE-37
  • aflibercept
  • alemtuzumab
  • ALVAC-CEA/B7.1
  • amrubicin hydrochloride
  • astuprotimut-r
  • AVX-701
  • belagenpumatucel-L
  • belinostat
  • bevacizumab
  • bexarotene
  • bortezomib
  • BP-GMAX-CD1
  • brentuximab vedotin
  • brivudine
  • Cadi-05
  • capecitabine
  • catumaxomab
  • CB-10-01
  • CEA-TRICOM
  • cetuximab
  • CG-201
  • cladribine
  • CMLVAX-100
  • CTL901
  • CTP-37
  • CVac
  • DCVax-prostate
  • denileukin diftitox
  • E-75
  • elliptinium acetate
  • enzastaurin hydrochloride
  • epirubicin
  • erlotinib
  • everolimus
  • fowlpox-PSA vaccine
  • galiximab
  • golnerminogene pradenovec
  • GRNVAC1
  • GV-1001
  • GV-1002
  • GVAX
  • GVX-3322
  • HBP-347
  • Her-2/Neu peptides
  • ibritumomab tiuxetan
  • IGN-101
  • ImmunoVEX tri-melan
  • IMO-2055
  • INGN-225
  • inotuzumab ozogamicin
  • interferon (alpha)
  • interferon (alpha2b)
  • interferon (gamma)
  • interferon alfa-2b
  • interferon alpha-2b
  • irinotecan hydrochloride
  • larotaxel
  • MAGE-3-TK
  • masitinib
  • ME-103
  • MGN-1601
  • mitoxantrone
  • MSI vaccine
  • MVA-BN
  • MVA-BN Her-2 vaccine
  • nadroparin
  • nimotuzumab
  • Norelin
  • obinutuzumab
  • oblimersen sodium
  • ofatumumab
  • Onyvax-105
  • OTS-102
  • paclitaxel
  • panobinostat
  • PANVAC-VF
  • pDOM-PSMA27
  • PEP-223
  • pixantrone
  • poly-ICLC
  • PR1:169-177 peptide
  • pralatrexate
  • PROSTVAC
  • PX-104.1
  • razoxane
  • Reditux
  • Reximmune-C
  • rhIFN-alpha
  • rindopepimut
  • rituximab
  • romidepsin
  • SAI-EGF
  • sobuzoxane
  • Stimuvax
  • sunitinib malate
  • tegafur + uracil
  • temsirolimus
  • teniposide
  • TG-4001
  • TG-4010
  • thymalfasin
  • TroVax
  • TS-1
  • verpasep caltespen
  • VX-001
  • zanolimumab
  • ZYC-300
Show More
Pricing
Get Notified
Email me when related reports are published